drugset / Trial / NCT00005629
Vaccine Therapy in Treating Patients With Liver Cancer
Phase 1/2
Completed
6 enrolled
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH) · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy in treating patients who have liver cancer.
Timeline
- Start
- 1999-07
- Primary completion
- 2002-05
- Completion
- 2002-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AFP gene hepatocellular carcinoma vaccine | Vaccine | 100 ug | Other |
| Subject | AFP gene hepatocellular carcinoma vaccine | Vaccine | 500 ug | Other |
| Subject | AFP gene hepatocellular carcinoma vaccine | Vaccine | 1000 ug | Other |
| Background | incomplete Freund's adjuvant | Other / unclassified | 2 ml | Other |